Bristol-Myers to Pay $11 Billion to License Cancer Drug
Prior: P: 235.7
New: N: -
Prior: Prior: 235.7
New: New: -
-
Prior: Prior: 6.98
New: New: -
Prior: Prior: 49
New: New: -
Latest News
- Digging into my HSA accounts taught me an important five-figure lesson in investment fees
- Anduril secures $30.5 billion valuation in latest fund raise
- I want to buy a house — but the market seems so lousy. Should I just invest my savings and stick to renting?
- Public markets primed for US IPO revival despite tariff uncertainty, NYSE President Martin says
- Daily Spotlight: Argus Adjusts S&P 500 EPS Estimates
- Electric truck startup Bollinger exits court receivership after paying back founder who sued